Small LDL Particle Count and Your Genetics
Small LDL particle count — a measure of the concentration of small, dense low-density lipoprotein particles in the bloodstream — provides cardiovascular information that extends beyond what standard total LDL cholesterol levels capture. LDL particles circulate in multiple sizes: large, buoyant LDL particles differ metabolically and structurally from small, dense LDL particles, which may be cleared from circulation more slowly and have distinct interactions with arterial structures. The genetic determinants of small LDL particle concentration are less extensively characterized than those of total LDL cholesterol, and the genomic loci identified in genome-wide analyses of this trait reflect a distinct underlying biology not fully captured by conventional lipid measurements.
What is small LDL particle count?
LDL cholesterol is not a uniform molecular species — LDL particles circulate in a range of sizes, from large, buoyant particles to small, dense particles. Small dense LDL (sdLDL) particles have distinct biophysical properties compared with large buoyant LDL: they have a lower cholesterol-to-protein ratio, are cleared more slowly by hepatic LDL receptors, and may interact with arterial proteoglycans differently. Research has explored whether the proportion of small versus large LDL particles provides cardiovascular risk information beyond total LDL cholesterol concentration.
Small LDL particle count is measured as part of advanced lipoprotein profiling that distinguishes LDL particle subclasses by size and concentration. These more detailed lipid panels capture aspects of LDL biology that standard clinical measurements do not. Genetic variants influencing LDL particle size distribution represent a distinct layer of heritable cardiovascular risk information, and the loci that influence particle size often differ from those that influence total LDL cholesterol levels.
Research Base: Moderate.
The genetics of small LDL particle count
The genetic architecture of small LDL particle concentration differs from that of total LDL cholesterol. While hundreds of loci contribute to overall LDL levels, the variants that specifically affect particle size distribution tend to emerge from studies focusing on lipoprotein subclass phenotypes rather than total lipid measurements. The smaller number of identified loci for small LDL particle count reflects the early stage of genomic discovery for subclass traits relative to conventional lipid measures.
The genomic region near ANKRD17 shows the strongest genetic signal for small LDL particle concentration in the available analyses. ANKRD17 encodes a protein containing ankyrin repeat domains involved in intracellular signaling processes. The appearance of this locus in small LDL particle analyses reflects the complex regulatory biology underlying lipoprotein particle size, which involves cellular processes extending beyond classic lipid synthesis and transport.
The ALB locus — near the gene encoding albumin, the most abundant circulating protein in human blood — has also appeared in analyses of lipoprotein subclass traits. Albumin functions as a carrier protein for a broad range of endogenous molecules including lipids, and the ALB genomic region has shown associations with lipid-related phenotypes in population studies. The precise mechanism linking this locus to particle size distribution continues to be explored.
ADAMTS3, a gene in the ADAMTS metalloproteinase family, represents another locus emerging in small LDL particle analyses. ADAMTS family proteins are involved in extracellular matrix remodeling, and their appearance in lipoprotein subclass analyses suggests that extracellular matrix biology may influence aspects of lipoprotein particle assembly or modification.
RASSF6 is an additional locus in this trait's genetic profile. Members of the Ras association domain family are involved in cellular signaling cascades, and variants near RASSF6 have appeared in analyses of advanced lipid particle phenotypes.
The limited gene set in this profile reflects genuine differences in the genetic architecture of particle-size traits versus conventional lipid traits — a pattern consistent with the finding that some lipid loci specifically influence particle size subclasses rather than aggregate lipid concentrations.
A genome-wide association study profiling 72 lipoprotein subclass and triglyceride traits in a Finnish population cohort found that 30 established lipid loci showed stronger genetic associations with particle-size subclass traits — including small LDL particle concentration — than with conventional total lipid measures. Five novel loci were identified that associate specifically with lipoprotein subclass phenotypes rather than conventional lipid levels, highlighting the additional heritable variation captured by subclass analysis (Davis et al., 2017).1
What the research says
The genetic study of lipoprotein particle subclasses has expanded understanding of heritable cardiovascular risk biology. Because standard clinical lipid measurements represent aggregate quantities rather than particle-level detail, subclass GWAS analyses reveal additional genetic architecture not captured by conventional lipid panels.
A 2017 study examining 72 lipoprotein subclass traits in a Finnish population cohort found that many established lipid loci — originally identified through standard total cholesterol, LDL, HDL, and triglyceride measures — show stronger associations with particle-size subclass phenotypes, suggesting that particle-size effects may represent the primary biological signal underlying some conventional lipid GWAS findings. Novel loci discovered in this analysis — including those influencing specifically small LDL particle concentration — would not have been identified through conventional lipid measurement alone (Davis et al., 2017).
The identification of loci near ANKRD17, ALB, and ADAMTS3 in small LDL particle analyses illustrates that the biology of particle size distribution involves cellular processes extending beyond classical lipid biosynthesis pathways. This is consistent with the known complexity of lipoprotein remodeling, which involves extracellular enzymes, transfer proteins, and receptor interactions that collectively determine the size distribution of circulating LDL particles.
How small LDL particle count affects you
Small LDL particle count provides a more detailed view of LDL-associated cardiovascular risk than total LDL concentration alone. Research has investigated whether individuals with a higher proportion of small dense LDL particles face different cardiovascular risk profiles than those with predominantly large buoyant LDL, even when total LDL concentrations are similar.
The genetic variants in your ExomeDNA small LDL particle profile reflect inherited differences in LDL particle size distribution. As with total LDL, the genetic component interacts with dietary patterns, physical activity, body composition, and metabolic factors that influence lipoprotein subclass distribution. Diets high in refined carbohydrates and simple sugars tend to shift lipoprotein profiles toward smaller, denser particles in many individuals, independent of genetic background.
Understanding your small LDL particle genetics adds a layer of detail to your lipid risk picture that complements standard total LDL cholesterol measurements. This information is most useful when interpreted alongside other lipid measurements and individual cardiovascular risk factors by a qualified clinician.
Working with your small LDL particle profile
The same lifestyle factors that support favorable total LDL levels also tend to improve LDL particle size distribution. Reducing intake of refined carbohydrates and simple sugars, increasing dietary fiber, and incorporating healthy unsaturated fats from sources such as nuts, olive oil, and fatty fish have been associated with more favorable lipoprotein subclass profiles in population research.
Regular aerobic exercise has been associated with favorable shifts in LDL particle size distribution across multiple population cohorts. Weight management also influences lipoprotein subclass profiles: excess body weight is associated with a higher proportion of small, dense LDL particles in many studies, and weight reduction tends to shift the balance toward larger particles.
If your ExomeDNA profile shows genetic variants associated with higher small LDL particle count, discussing this alongside your measured lipid profile with a healthcare provider provides the most complete picture. Advanced lipoprotein profiling tests that directly measure particle subclasses are available in clinical settings and can confirm whether genetic predisposition is reflected in actual circulating particle distributions.
Related traits and genes
Small LDL particle count is genetically correlated with several other lipid phenotypes. Total LDL cholesterol levels and small LDL particle count share some genetic loci, but many loci are distinct — reflecting the partially independent biology of particle concentration versus particle size distribution. Triglycerides show stronger genetic overlap with small dense LDL than with total LDL, consistent with the known metabolic relationship between triglyceride-rich lipoproteins and LDL particle remodeling.
HDL cholesterol levels are inversely correlated with small LDL particle concentration in both genetic and epidemiological analyses: individuals with lower HDL often show higher small dense LDL concentrations, and some genetic loci show effects on both phenotypes. Related ExomeDNA traits include total LDL cholesterol, HDL cholesterol, triglycerides, VLDL levels, and coronary artery disease risk.
The genes featured in this profile — ANKRD17, ALB, ADAMTS3, and RASSF6 — represent genomic loci with emerging roles in lipoprotein subclass biology that are distinct from the classic lipid gene set centered on cholesterol synthesis and transport.
Frequently asked questions
What is small LDL particle count, and how is it different from total LDL?
Total LDL cholesterol measures the aggregate amount of cholesterol carried in all LDL particles combined. Small LDL particle count specifically measures the concentration of small, dense LDL particles — a distinct subclass with different biophysical properties than large buoyant LDL. These smaller particles may be cleared from circulation more slowly and have distinct interactions with arterial structures. Research continues to examine whether small LDL particle count provides independent cardiovascular risk information beyond what total LDL captures.
What genes are associated with small LDL particle count?
This trait profile is associated with loci near ANKRD17, ALB, ADAMTS3, and RASSF6. Unlike the genes most strongly associated with total LDL cholesterol — which tend to be classic lipid synthesis and transport genes — the loci identified for small LDL particle concentration include genes involved in intracellular signaling, extracellular matrix remodeling, and plasma protein function. This reflects the distinct biology underlying particle size distribution versus total particle concentration.
Why are small LDL particles of cardiovascular interest?
Small, dense LDL particles have several biophysical properties that have attracted cardiovascular research attention: they are cleared from circulation more slowly than large LDL particles, may bind more readily to arterial proteoglycans, and are more susceptible to oxidative modification. Whether small LDL particle concentration provides independent cardiovascular risk prediction beyond total LDL continues to be examined in large population studies, with evidence suggesting that subclass analysis captures additional heritable risk not detected by standard lipid panels.
What lifestyle factors influence small LDL particle count?
Dietary composition — particularly reduced intake of refined carbohydrates and simple sugars combined with increased fiber and healthy fat consumption — is associated with more favorable lipoprotein subclass profiles in population research. Regular aerobic exercise and weight management are also associated with favorable shifts in LDL particle size. These lifestyle factors tend to reduce the proportion of small dense LDL and support large buoyant LDL, independent of genetic background.
Is small LDL particle count substantially heritable?
Lipoprotein subclass traits including small LDL particle concentration are heritable, though the proportion of variation explained by genetics is less well-characterized than for total LDL cholesterol, where decades of large-scale GWAS research have mapped hundreds of contributing loci. The smaller number of identified loci for small LDL particle count reflects both the early stage of subclass genomic discovery and the distinct genetic architecture of particle size relative to total lipid concentration.
By the ExomeDNA Research Team
This genetic information is for educational and informational purposes only. Results do not constitute a clinical evaluation. Consult a qualified healthcare professional for questions about your lipid levels or cardiovascular health.
Data Sources
- GWAS Catalog: genome-wide association study variants linked to small LDL particle concentration
- Open Targets: gene prioritization and literature summary
- dbSNP: variant functional annotation
- ClinVar: clinically-reported variant significance
References
- Davis JP, et al. (2017). Common, low-frequency, and rare genetic variants associated with lipoprotein subclasses and triglyceride measures in Finnish men from the METSIM study. PLoS Genet 13(10):e1007079. PMID 29084231